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Hydrofluoric acid (HF) is an aqueous form of hydrogen fluoride (Lewis, 1993) 
that typically emits a colorless or fuming irritate gas at room temperature (Hance, 
Solomon, Salmon, Fall, & Cass, 1997).  As one of the more commonly used inorganic 
compounds in industry today, hydrofluoric acid is highly corrosive and will deteriorate 
materials such as concrete, glass, natural rubber, and metal alloys that contain silica (EPA 
Chemical Profile, 1987).  From a worker inhalation exposure standpoint, the 
Occupational Safety and Health Administration (OSHA) has set inhalation limits for 
hydrofluoric acid at 3 ppm (2.5 mg/m3)(OSHA, 2001).   
Hydrofluoric acid is used in numerous applications in the semiconductor industry 
in the form of quartz and metal etching; but along with being very beneficial, it also has 
numerous disadvantages.  From a dermal contact standpoint, hydrofluoric acid eventually 
causes a very corrosive and unique chemical burn.  Upon skin contact, hydrofluoric acid 
causes tissue destruction by two methods.  One, the unstable fluoride ions penetrate 
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tissues and adsorb calcium and magnesium, which can lead to failure of various internal 
organs.  Second, the hydrogen ion causes a deep corrosive burn that is slow-to-heal 
(American Chemical Society, 1997).  Consequently, knowledge of the toxicological 
effects, as well as treatment methods pertaining to hydrofluoric acid exposure, are vital. 
From a dermal exposure standpoint, various studies have been preformed on the 
treatment methodologies for hydrofluoric acid exposure.  Upon exposure, treatment must 
be administered immediately or the threat of death is substantial (Bracken, Cuppage, 
McLaury, Kirmin, & Klaassen, 1985).  Two possible methods of treatment for skin 
exposure exist.  The more commonly used compound is calcium gluconate, with an 
alternative but less-utilized organic material known as Zephiran (Dunn, MacKinnon, 
Knowlden, Billmaier, Derelanko, Rusch, Naas, & Dahlgen, 1992).  One study indicated 
that the injection of calcium gluconate can be reasonably effective at neutralizing 
hydrofluoric acid that has penetrated bodily tissues (Dunn, et al., 1992), the chemical 
composition of calcium gluconate may not lend itself to topical-oriented treatment 
methodologies to the extent that Zephiran can. 
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CHAPTER 1  
Statement of the Problem 
Introduction 
In the United States there are more than 1,000 cases reported every year for 
overexposure to hydrofluoric acid (HF) (American Chemical Society, 1997).  
Hydrofluoric acid (HF) is an aqueous form of hydrogen fluoride (Lewis, 1993) that 
typically emits a colorless or fuming irritate gas at room temperature (Hance, Solomon, 
Salmon, Fall, & Cass, 1997).  Hydrofluoric acid is one of the more commonly used 
inorganic compounds in industry today, hydrofluoric acid is highly corrosive and will 
readily deteriorate materials such as concrete, glass, natural rubber, and metal alloys that 
contain silica (EPA Chemical Profile, 1987).   
In 1997, 247,000 tons of hydrofluoric acid was used for commercial production 
processes.  Hydrofluoric acid is needed for the fabrication of aluminum and stainless 
steel, etching glass and circuit boards, and producing stain removers, solvents, resins, and 
pharmaceuticals (Constellation Power Source, 2001).  The refrigeration industry is one of 
the largest users of hydrofluoric acid.  This industry uses hydrofluoric acid to produce 
fluorocarbon, fluoropolymers, and other refrigerant compounds hydrofluoric acid is one 
of the strongest inorganic acids used by this industry today (Hance, et al., 1997 & 
Westervelt, 2001 & Siegel & Heard, 1992).  Many processes preformed by the 
semiconductor industry use very hazardous chemicals.  Hydrofluoric acid is one such 
chemical that is very hazardous.  Hydrofluoric acid is very important to the 
semiconductor industry, but it also is very toxic to humans.  Dermal exposure to 
hydrofluoric acid can cause serious and painful burns to the skin.  In some cases these 
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burns can be life threatening, specialized first aid and medical treatment is required for 
any exposure to hydrofluoric acid (Honeywell Inc., 1998).    
Treatment methods for exposure to hydrofluoric acid vary depending on what 
area was exposed, be it dermal or eye contact, inhalation or ingestion (Honeywell Inc., 
1998).  In regards to treating dermal burns that occur from exposure to hydrofluoric acid, 
studies have indicated that calcium gluconate is the preferred method for long-term 
treatment (Bracken, et al., 1985), while other studies have indicated that Zephiran ® is 
the better choice for treating dermal burns associated with short term exposure to 
hydrofluoric acid (Dunn, et al., 1992).  The focus of this paper is to compare the use of 
calcium gluconate and Zephiran for the treatment of dermal based hydrofluoric acid 
exposures and try to identify which treatment is most desirable by industry today. 
Purpose 
The purpose of this study was to compare the use of calcium gluconate and 
Zephiran for the treatment of dermal based hydrofluoric acid exposure.  In order to 
accomplish this, a review of pertinent literature was conducted.  An analysis of policies 
and procedures for treating dermal exposure to hydrofluoric acid from a number of 
different universities and industries was conducted during the Fall semester of 2002.   
Goals of the Study 
The researcher has made three goals.  They are: 
1. Identify the toxicity and physical properties of hydrofluoric acid. 
2. Examine the physical implications associated with dermal-based exposure 
to hydrofluoric acid. 
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3. Determine topical-based treatment methodologies for dermal hydrofluoric 
acid exposure as it relates to the use of Zephiran verses calcium gluconate. 
4. Determine the cost comparison between Zephiran and calcium gluconate 
in the treatment of dermal exposure to hydrofluoric acid.   
5.      Determine which topical` based treatment (Zephiran or calcium 
gluconate) is most desired by industry and universities today in treating dermal-
based exposures to hydrofluoric acid.   
Background and Significance 
 In 1995, an Australia laboratory technician spilled between 100 and 230 ml of 
hydrofluoric acid onto his lap.  The technician rinsed the exposed area with water at 6 
liters/minute, but still sustained burns to 9% of his body.  The technician did not 
immediately remove the contaminated clothing and did not receive any first-aid ointment 
(such as calcium gluconate or Zephiran) to the exposed area.  Several days after the 
accident occurred, the technician’s right leg was amputated.  Fifteen days after being 
exposed to hydrofluoric acid, the technician died from multi-organ failure.  After his 
death, an accident analysis was conducted.  The analysis identified that no emergency 
procedures, safety equipment, or personal protective equipment was available for 
handling highly concentrated amounts of hydrofluoric acid.  The investigation concluded 
that the death could have been prevented if the appropriate controls would have been in 
place (University of Washington Environmental Health and Safety, 2000).   
 Situations like the one discussed in the previous paragraph are not that 
uncommon.  Numerous injuries occur every year from exposure to hydrofluoric acid.  
The main reasons are: emergency eyewash and safety showers were not available, 
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individuals exposed were not wearing appropriate personal protective equipment, 
individuals did not immediately remove their contaminated clothing, and did not have the 
appropriate first aid ointment (such as calcium gluconate or Zephiran) on hand to apply 
to the exposed area (Queensland Government, 2002).  Figure 1 shows the occupations, 
costs associated, days off of work due to and activities preformed when exposed to 
hydrofluoric acid. 
Figure 1 - Hydrofluoric acid injuries-Workers’ Compensation claims July 1992-
June 2000 
OCCUPATION HF EXPOSURE DAYS OFF COST $ 
Chemist Cleaning fume 
cupboard 
0 $60.00 
Boilermaker Cleaning Weld 22 $12,415.00 
Boilermaker Filling Acid Dip Tank 84 $7,109.00 
Boilermaker Picking Up Drums 22 $2,660.00 
Excavator Siphoning HF 354 $50,987.00 
Forklift Driver Cleaning Aluminum 8 $838.00 
Operator Placing Lid On Drum 10 $1,470.00 
Store Person Packing HF Drums 3 $250.00 
Occupational 
Not Stated 
Putting HF Drums 
Away 
28 $3,860.00 
Total HF Claims 9 Total HF Days Off 531 
Total HF Claims 
$79,649.00 
*Total Acid 
Claims 412 
Total Days OFF
2,185 
Total Acid Claims 
$313,054.00 
* Some claims for HF may be in the category for all acid injuries because the type of acid is not always 
specified. 
Note: From Queensland Government. (2002, April).Hydrofluoric acid poisoning and burns. 
Retrieved September 25, 2002 from: http://www.whs.qld.gov.au/alerts/02i04.pdf 
 
Figure 1 shows that hydrofluoric acid burns only makes up 2.2% of the total acid 
burn cases.  The significance of this statement is that hydrofluoric acid burns make up 
24% of the lost work time and 25% of the compensation costs for total acid burn cases.  
This identifies the significance that having the right treatment to treat hydrofluoric acid 
burns can save thousands of dollars in compensation costs and hundreds of lost 
workdays.  The focus of this paper is to compare the use of calcium gluconate and 
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Zephiran  for the treatment of dermal based hydrofluoric acid exposures and try to 
identify which treatment is most cost effective and predominately used by industry today.  
Assumptions 
 The researcher has made four assumptions.  They are: 
1. It is assumed that all companies either use Zephiran or calcium gluconate in 
treating hydrofluoric acid exposures.  
2. It is believed that all written material received from companies will provide 
accurate data. 
3. It is presumed that the semiconductor industry and university organizations are 
the major users of hydrofluoric acid. 
4. It is assumed that all companies that use hydrofluoric acid are aware of the 
hazards and dangers that this chemical possess. 
Limitations 
 The researcher has made two limitations.  They are: 
1. No human studies have been preformed to find out toxicology levels of 
hydrofluoric acid for humans.  Only animal studies have been completed in determining 
lethal dose limits.   
2. The research focuses on dermal treatment methodologies for in the 
semiconductor industry and collects data from only one semiconductor facility. 
Definition of Terms 
 Terms pertinent to the study are defined below: 
Calcium gluconate - Calcium gluconate gel is a topical antidote for hydrofluoric 
acid burns.  Calcium gluconate works by combining with hydrofluoric acid to form 
insoluble calcium fluoride.  This helps prevent the extraction of calcium from tissues and 
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bones. Calcium gluconate also helps reduce deep painful burns.  Calcium gluconate gel 
should be present whenever someone is working with hydrofluoric acid (Life Safety 
Associates, 2002) 
 Hydrofluoric acid – “Hydrofluoric Acid (HF) is one of the strongest and most 
corrosive acids known. Therefore, special safety precautions are necessary when using 
this chemical. HF is used in a variety of applications including glass etching, pickling of 
stainless steel, removal of sand and scale from foundry castings and as a laboratory 
reagent. Anyone using HF should implement the following safety measures. Most 
importantly, do not assume that dilute solutions do not require special precautions 
(Department of Environmental Health, Safety and Risk Management, 2002 ¶#1)!” 
Zephiran  - “Brand of benzalkonium chloride, NF, a mixture of  
alkylbenzyldimethylammonium chlorides, is a cationic quaternary ammonium surface-
acting agent. It is very soluble in water, alcohol, and acetone. Zephiran is supplied as a 
1:750 aqueous solution; further dilution may be appropriate depending on usage.  
Aqueous solutions of Zephiran are neutral to slightly alkaline, generally colorless, and 
nonstaining. They have a bitter taste, aromatic odor, and foam when shaken (Sanofi-
Synthelabo, Inc., 1999, ¶#1)” 
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CHAPTER 2 
Review of Literature 
Introduction 
The purpose of the literature review was to provide an examination of the 
toxicological effects of hydrofluoric acid.  Another objective of the literature review was 
to provide an examination of the physical implications associated with dermal-based 
exposure to hydrofluoric acid.  The body of the chapter analyzed topical-based treatment 
methodologies for dermal hydrofluoric acid exposure as it relates to the use of Zephiran 
verses calcium gluconate.  In addition, a summary of the differences between the 
treatment methods will be provided.  Finally, determining the cost comparison between 
Zephiran and calcium gluconate in the treatment of dermal exposure to hydrofluoric 
acid.   
Toxicity of Hydrofluoric Acid 
Toxicity is defined as the harmful effects that some substances or some 
medications have on the human body.  The toxic effect of a chemical can be brief, last 
weeks to a few months, and in some cases result in permanent damage (University of 
Oxford, 2002).  Hydrofluoric acid is an extremely toxic and corrosive substance that exits 
either as a gas, liquid, or solid (National Safety Council, 1988).  Hydrofluoric acid can 
also be referred to as anhydrous hydrogen fluoride, aqueous hydrogen fluoride or HF-A 
(National Institute for Occupational Safety and Health, 2000).  Hydrofluoric acid is an 
aqueous form of hydrogen fluoride (Lewis, 1993).  Hydrofluoric acid is one of the more 
commonly used inorganic compounds used in industry today, and is highly corrosive.  It 
will readily attack materials such as concrete, glass, natural rubber, and metal alloys that 
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contain silica (Environmental Protection Agency Chemical Profile, 1987).  Some unique 
proprieties of hydrofluoric acid are shown in Figure 2. 
Figure 2 – Proprieties of Hydrofluoric Acid 
NIOSH REL: TWA 3 ppm (2.5 mg/m3) C 6 ppm (5 mg/m3) [15-
minute] Exposure Limits: 
OSHA PEL: TWA 3 ppm 
Boiling Point: 67 °F 19.44 °C 292.4 K 527 R 
Flammability:  Nonflammable Gas Lower Explosive Limit: N/A 
Vapor Pressure:  783 mmHg Upper Explosive Limit: N/A 
Incompatibilities: Corrosive to metals. Will attack glass and concrete. 
Target Organs: Eyes, skin, respiratory system, bones 
Symptoms: Irritation eyes, skin, nose, throat; pulmonary edema; eye, skin burns; bone changes 
Exposure Routes:  Inhalation, skin absorption (liquid), ingestion (solution), skin and/or eye contact 
Physical 
Description: 
Colorless gas or fuming liquid (below 67°F) with a strong, irritating 
odor.  
 
Hydrofluoric acid, in either a gas or liquid form can cause serious respiratory 
damage.  Dermal destruction can occur on contact, with the possibility of causing 
permanent damage.  This substance is often referred to as a cellular poison.  A dermal 
overexposure to hydrofluoric acid can result in the formation of deep ulcers that are slow 
to heal.  From an acute exposure standpoint, it is estimated that exposure to air 
concentrations ranging from of 50 to 250 ppm of hydrofluoric acid for five minutes can 
be lethal (Hathaway, Proctor, Hughes, & Fischman, 1991). 
This estimation coincides with these hydrofluoric acid inhalation studies 
involving rats.  Morris & Smith, 1982 showed that an exposure of 166 ppm for a six-hour 
period results in 100% lethality.  In addition, Wohlslagel, Dipasquale, and Vernot (1976) 
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found that 100% lethality also occurred in rats when they were exposed to 1,765 ppm.  
Since hydrofluoric acid is so toxic, no human studies can ever be performed to determine 
the lethal dose.  However, in 1995, a laboratory technician splashed 100 mL of 
hydrofluoric acid on his lap and fifteen days later died as a result of the dermal exposure 
(University of Washington Environmental Health and Safety, 2000).  Thus, it could be 
stated the being dermally exposed to 100 mL of hydrofluoric acid may be the lethal dose. 
Physical Implications Associated with Exposure to Hydrofluoric Acid 
At least two forms of injury occur when hydrofluoric acid contacts human skin or 
other body tissues.  First, dehydration induced coagulative necrosis occurs immediately 
upon dermal contact.  The second form of injury occurs when hydrofluoric acid 
penetrates tissues and begins flowing through the bloodstream and depleting the body of 
needed calcium and magnesium (Bracken, Cuppage, McLaury, Kirmin, & Klaassen, 
1985).  Once absorbed into the body, hydrofluoric acid forms insoluble fluorine salts.  
This rapid fluoride salt formation process starts with the fluoride ions binding with 
calcium and magnesium molecules in the body (American Chemical Society (ACS), 
1997).  The fluoride ion causes liquefaction necrosis by forming insoluble calcium 
fluoride salts, which result in the destruction of soft and supportive tissues.  This forming 
process is generally associated with chemicals that have a high alkalinity value; not with 
chemicals that are highly acidic (ACS, 1997).  Hydrofluoric acid tends to act more like a 
base because of the fluoride ion binding action (Boyd, 2001).    
The chemical nature of hydrofluoric acid makes it difficult to neutralize.  It 
readily absorbs into the skin, causing a tissue destruction process that may lasts for days.  
Flushing the exposed area with water is an effective method for removing surface acid, 
but does not stop the fluoride ions that have already penetrated the skin.  Insufficient 
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amounts of calcium in the body can cause hypocalcemia.  Calcium is needed for cell life 
and cell regeneration.   A bond between fluoride ions and calcium inhabits cell existence 
and reproduction.  Hypocalcemia occurs when the heart function is diminished.  This 
results in an abnormal heartbeat, which may ultimately result in cardiac arrhythmia.  In 
addition to cardio related issues involving the heart the liver and kidney may also be 
damaged through hypocalcemia (ACS, 1997).  Figure 3 illustrates how hydrofluoric acid 
penetrates the skin and binds with calcium and magnesium.     
Figure 3 – Destruction Process of Hydrofluoric Acid 
 
 
Along with its ability to bind to calcium, the fluoride ion can also bind with 
magnesium to cause hypomagnesemia; low magnesium levels in the blood plasma.  This 
abnormality in the blood plasma can cause neuromuscular hyperirritability, which is the 
moving of muscles and nerves uncontrollably.  Another issue associated with 
hydrofluoric acid exposure is the formation of various soluble fluorinated salts within the 
body.  These highly toxic salts are direct cellular poisons that interfere with enzyme 
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mechanisms.  Then making these toxic salts direct cellular poisons.  The recovery process 
from hydrofluoric acid burns is very long and painful.  In some situations death has been 
the final outcome of being overexposed to hydrofluoric acid (ACS, 1997).  Figure 4 
illustrates how rapidly and deadly hydrofluoric acid can be when exposure occurs. 
Figure 4 - US Fatalities Due To Hydrofluoric Acid (HF) Burns 
Exposure % Body Splashed /Body Location 
Time To 
Death From 
Exposure 
Unclogging pipeline hose, 
coupling came loose 
30% / Arms, Face, and Neck 30 Minutes 
Pump hose came loose 40% / Face and Chest 3 ½ Hours 
Stepped on bucket 
containing 70% HF 
8% / Right Lower Leg, Foot, and Thigh 15 ½ Hours 
Splash from open drain 
valve 
N/A % / Arms, Chest, Face, and Left 
Leg 4 Hours 
Spill from open bucket 
containing 70% HF 
N/A % / Chest, Neck, and Face 30 Minutes 
Incorrect lockout, pump 
sprayed HF 
N/A % / No Details 30 Minutes 
Incorrect lockout, pump 
sprayed HF 
N/A % / Severe Lung Injury 2 ½ Hours 
Incorrect lockout, of HF 
drain line 
15% / Head, Neck, Shoulders, and Arms 4 Hours 
Pouring HF from drum to 
bucket  
40% / No Details  4 Hours 
Note: From Queensland Government. (2002, April). Hydrofluoric acid poisoning and burns. 
Retrieved September 25, 2002 from: http://www.whs.qld.gov.au/alerts/02i04.pdf 
Treatments for Dermal Exposure to Hydrofluoric Acid 
If hydrofluoric acid exposures are properly and promptly treated, the results can 
be successful.  However, improper treatment and/or delaying the treatment process can 
result in permanent cell damage or death.  The typical treatments (Zephiran® and 
calcium gluconate) focus on binding with hydrofluoric acid.   The treatments also prevent 
further tissue destruction from the depletion of calcium and magnesium (ACS, 1997).  As 
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previously mentioned, speed is of the utmost importance when treating hydrofluoric acid 
dermal exposures.  Honeywell, Inc. (previously known as AlliedSignal, Inc.), is the 
world’s leading supplier of hydrofluoric acid.  They publish a pamphlet titled, 
"Recommended medical treatment for hydrofluoric acid exposure".  This company 
extensively researched the treatment practices and methods for dermal hydrofluoric acid 
exposure.  Honeywell recommends flushing the affected area thoroughly with large 
amounts of cool running water no more than five minutes.  Once rinsing is completed, 
apply 0.13% Zephiran (benzalkonium chloride) solution or 2.5% calcium gluconate gel 
(Honeywell Inc., 1998).  DuPont is another large supplier of hydrofluoric acid.  Similar to 
Honeywell’s recommendation from a cleansing standpoint, their material safety data 
sheet states that exposed skin should be thoroughly rinsed with tap water for five 
minutes.  Any additional flushing is unnecessary and will delay topical treatment time.  
DuPont recommends applying 2.5% calcium gluconate gel to the exposed area.  No 
duration of time was specified for the application of calcium gluconate (ACS, 1997).  
Mallinckrodt Baker is the third leading supplier of hydrofluoric acid.  Mallinckrodt 
Baker’s material safety data sheet for treating exposure to hydrofluoric acid advises a 
fifteen to twenty minute water rinse if topical treatments are not available.  If treatments 
are available, rinse the effected area for five minutes.  Followed by the application of 
Hyamine 1622 (tetracaine benzethonium chloride) or 0.13% Zephiran (benzalkonium 
chloride) to the exposed area.  Contrary to this treatment methodology, the American 
Chemical Society stated that Mallinckrodt Baker’s material safety data sheet also 
provides a note to the treating physician.  This note states “it has been conclusively 
shown that flushing the affected area with water for one minute and then massaging 
calcium gluconate gel into the exposed area until pain ceases is the most effective first 
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aid treatment available” (ACS, 1997, ¶.25).  This quote cannot be located in the 
Mallinckrodt Baker material safety data sheet.  This raises a question about the validity of 
this source (ACS, 1997; Mallinckrodt Baker, 2001).  Why this discrepancy exists is 
unknown, but may be answered by research that has been previously done. 
In comparing the three major producers of hydrofluoric acid, it can be stated that 
there are inconsistencies between their treatment methods.  Mallinckrodt Baker states that 
Zephiran® should be used to treat exposures to hydrofluoric acid (Mallinckrodt Baker, 
2001).   Dupont claims calcium gluconate is more productive and should be used.  
Honeywell, Inc. states that either calcium gluconate or Zephiran® can be used to treat 
dermal exposure to hydrofluoric acid.  One treatment method must be more effective than 
that other, thus further research must be preformed to answer this question (ACS, 1997). 
Dermal Treatment Studies for Hydrofluoric Acid Burns 
Many studies have been performed on treatment methodologies for dermal 
exposure to hydrofluoric acid.  Two of these studies (Bracken, Cuppage, McLaury, 
Kirmin, & Klaassen, 1985; Dunn, MacKinnon, Knowlden, Billmaier, Derelanko, Rusch, 
Naas, & Dahlgen, 1992) have used rats and pigs for models in examining which 
treatment is most effective.  Bracken et al., 1985; McCulley, Whiting, Petitt, & Lauber, 
1983; researched exposure to hydrofluoric acid and indicated that calcium gluconate was 
an effective treatment in treating dermal exposure to hydrofluoric acid.  Two other 
studies (Dunn et al., 1992; McCulley, Whiting, Petitt, & Lauder, 1983) suggested that 
Zephiran® is a more effective method for treating dermal exposure to hydrofluoric acid. 
Dermal Exposure of Pigs 
Dunn et al. (1992) completed a study to determine what was the most effective 
treatment for dermal exposure to hydrofluoric acid.  Dunn et al. (1992) took Zephiran®, 
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10 % calcium gluconate injection, 2.5 % calcium gluconate topical treatment, 10 % 
calcium acetate, and iced Hyamine, and applied them to dermal hydrofluoric acid burns 
on twenty-four white male adolescent pigs.  Hair was removed from the back of each pig 
twenty-four hours prior to the application of hydrofluoric acid.  The pigs were 
anesthetized just prior to being exposed to hydrofluoric acid at the site of the removed 
hair.  These pigs were dermally exposed to 0.4 mL of 38% hydrofluoric acid.  The 
hydrofluoric acid was allowed to infiltrate the pig’s skin for nine, twelve, and fifteen 
minute time periods.  After the application of the hydrofluoric acid, exposed areas were 
then rinsed with tap water for 1.5 minutes.  The effects from dermal exposure to the pigs 
are shown in Figure 5 and Figure 6.  Figure 5 graphically identifies how destructive and 
caustic hydrofluoric acid can be.   
Figure 5 - Tissue samples of pig skin dermally exposed to hydrofluoric acid 
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Figure 6 - Details for Figure 5 
Section Sub Section Explanation of Detail 
a Epidermal inflammation-is the swelling of the first layer of skin.  
A 
b Dermal connective tissue necrosis-is death of cells in the second layer of skin that bind tissues together 
a Epidermal hyperkeratosis-is the decomposing of the first layer of skin.    
b Sub dermal chronic inflammation-is swelling in the second layer of skin B 
c Dermal connective tissue necrosis-is death of cells in the second layer of skin that bind tissues together 
a Sub dermal acute hemorrhage-is bleeding in the deepest layer of skin  
C 
b Sub dermal mineralization-is the build up of bile salts in the deepest layer of skin 
D a 
Sub dermal adipose tissue necrosis-is the death of fat in the form 
of triglycerides in the layer of skin that comes in contact with 
the bone 
Note: From Dunn, B.J., MacKinnon, M.A., Knowlden, N.F., Billmaier, D. J., Derelanko, M.J., 
Rusch, G.M., Naas, D.J. Dahlgen, R.R. (1992). Hydrofluoric acid dermal burns. Journal of 
Occupational Medicine. 34, (9) 907. Permission Given. 
 
Figure 6 defines all the medical terminology stated in figure 5.  Figure 5 and 6 identify 
the significance on how important it is to understand and recognize how toxic and 
corrosive hydrofluoric acid can be. (Dunn et al., 1992) 
The study was completed to determine what the most effective treatment for 
dermal exposure to hydrofluoric acid.  Pigskin was used for a model; the findings of this 
study are graphically represented in Figure 7.  Figure 7 shows the mean efficacy scores of 
the different treatments that were used in the experiment.  The pig study indicated that 
Zephiran® is the most effective treatment for short-term exposure to hydrofluoric acid.   
2.5 % calcium gluconate is the most effective treatment for long-term exposure to 
hydrofluoric acid.  It should be noted that 10 % calcium acetate soaks were presented as 
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being the most effective treatment method for a hydrofluoric acid exposure period of 
fifteen minutes.  The pig study also indicated that topical treatments were more effective 
than injection treatments (Dunn et al., 1992). 
Figure 7 Mean efficacy scores for HF exposed skin receiving various treatments 
 
Note: From Dunn, B.J., MacKinnon, M.A., Knowlden, N.F., Billmaier, D. J., Derelanko, 
M.J., Rusch, G.M., Naas, D.J. Dahlgen, R.R. (1992). Hydrofluoric acid dermal burns. 
Journal of Occupational Medicine. 34, (9) 905. Permission Given. 
Dermal Exposure of Rats 
An experimental study by Bracken, Cuppage, McLaury, Kirmin, and Klaassen 
(1985) was performed to determine what treatment was most effective for dermal 
exposure to hydrofluoric acid.  White male Sprage Dawley rats weighing between 200 to 
300 grams were used for this study.  Forty-eight hours prior to this experiment, the hair 
on the hind legs of rats was removed.  The rats were sedated orally and given similar 
amounts of hydrofluoric acid.  Two eye drops of 70% hydrofluoric acid were put on the 
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hind legs of each rat.  After the placement of hydrofluoric acid, the exposed areas were 
then rinsed with tap water for five minutes.  In this study Zephiran®, calcium gluconate, 
A+D ointment, aloe gel, and magnesium ointment were applied to the areas that were 
exposed to hydrofluoric acid (Bracken et al., 1985).   
The results of the Bracken et al. (1985) study indicated that dermal injury from 
the hydrofluoric acid exposure occurred instantaneously in rats.  Figure 8 shows the 
efficiency of each treatment that was used in this experiment.  It illustrates the treatment 
method verses the size of the surface area during a six, twenty-four, and forty-eight hour 
period.  The 2.5% calcium gluconate (CaG) had a 4% decrease in surface area between 
hour 6 and hour 24.  What is remarkable is that there was a 40% decrease in surface areas 
between the 24-hour period and the 48-hour period when using calcium gluconate.  This 
study indicated that calcium gluconate is the most effective treatment in decreasing and 
delaying hydrofluoric acid burn development.  The study also indicated that Zephiran® is 
not effective in treating dermal exposure to hydrofluoric acid (Bracken et al., 1985). 
Figure 8: Efficiency of topical burn treatments at various periods after HF 
application 
Note: From Bracken, W. M., Cuppage, F., McLaury, R.L., Kirmin, C., & Klaassen, C. 
(1985). Comparative effectiveness of topical treatments for hydrofluoric acid burns. Journal 
of Occupational Medicine. 27 (10) 736. Permission Given. 
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Comparing Dermal Treatment Studies for Hydrofluoric Acid Burns 
The treatment of hydrofluoric acid burns in the workplace is necessary to 
minimize the extent of tissue damage.  Bracken et al. (1985) and Dunn et al. (1992) 
experimented with different treatment methods for skin that was exposed to hydrofluoric 
acid.  The study by Dunn et al. (1992) stated that Zephiran® was the most effective 
treatment for short-term exposure to hydrofluoric acid but was not as effective for long-
term exposure.  Bracken et al. (1985) concluded that calcium gluconate is the most 
effective for treating skin that had been exposed to hydrofluoric acid.  Bracken et al. 
(1985) also indicated that Zephiran® is not an effective treatment for dermal exposure to 
hydrofluoric acid.  The results obtained from the Bracken et al. (1985) and Dunn et al. 
(1992) studies suggested that calcium gluconate was overall the most effective treatment 
in decreasing and delaying hydrofluoric acid burns.  These two studies (Bracken et al., 
1985 & Dunn et al., 1992) were conducted on laboratory animals, not on any human 
subjects.   
A characteristic that appears to be overlooked by both the Bracken et al. (1985) 
and Dunn et al. (1992) studies was the comparison of rat and pig skin to that of human 
skin.  A dermal study tried to use integrins to obtain a better understanding of wound 
healing and vesication (Zhang & Monteiro-Riviere, 1997).  The study performed by 
Zhang and Monteiro-Riviere (1997) revealed that pigskin has similar characteristics to 
human skin.  Thus indicating that pigskin is an accurate model to use when evaluating the 
potential toxic effects on human skin (Zhang & Monteiro-Riviere, 1997).  Another 
dermal study tried to identify penetration and permeation of griseofulvin across rat and 
human skin (Ritschel & Hussain, 1988).  Ritschel and Hussain (1988) identified that 
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dimethylacetamide and diethylene glycol monoethylether ointment is absorbed faster 
through rat skin than human skin.  The study determined that human skin is much less 
permeable than rat skin (Ritschel & Hussain 1988).  An analysis of the previously 
mentioned hydrofluoric acid dermal exposure studies (Dunn et al., 1992 & Bracken et al., 
1985), as well as two skin compassion studies (Zhang & Monteiro-Riviere, 1997 & 
Ritschel & Hussain, 1988), concludes that the results of the pig study performed by Dunn 
et al. (1992) was more accurate because pig skin is similar to that of human skin.  This 
gives more validity to the statement that calcium gluconate is more efficient at treating 
dermal exposure to hydrofluoric acid (Dunn et al., 1992). 
Cost Comparison Between Calcium Gluconate and Zephiran® 
 A cost comparison analysis is the breaking down of costs between two or more 
items using some form of common criteria.  These criteria could constitute market cost, 
availability, shipping costs, storage costs, or even labor costs.  A cost comparison model 
can be derived from the criteria collected.  The cost comparison model identifies the 
criteria for each item analyzed and reports the costs separately using a form of visual 
illustration (Dictionary.com, 1997).  The cost comparison model used in this review of 
literature will be cost versus accessibility.  One reason for selecting this model was 
because cost plays an important roll when budgeting for the future.  Another reason is 
that exposure to hydrofluoric acid can usually happen in any number of locations in a 
facility, thus it is important that the treatment can be available in different places.  In the 
case of medical treatments, a cost comparison analysis should only be the determining 
factor when different treatment methods demonstrate the same results during and after 
treatment methodologies.  When two separate compounds are used to treat the same 
chemical exposure it is vital the more efficient treatment method is used.   
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Benzalkonium chloride, more commonly know as Zephiran, is a quaternary 
ammonium compound and is mainly used as a medical disinfecting agent (University of 
Oxford, 2002).  In addition to treating burns associated with exposure to hydrofluoric 
acid, Zephiran is generally used an antiseptic.  It treats mouth ulcers, gum disease, and 
other infections that occur in the mouth and throat (Xrefer, 2002).  Zephiran also is an 
ingredient that is put into creams, paints, deodorants, mouthwashes, aftershaves and 
lotions for treating a variety of dermal skin disorders (Xrefer, 2002 & Total Skin Care, 
2002).  
Another cost benefit of using Zephiran than any other ammonium compounds is 
that Zephiran is a non-prescription drug, and is recommended for use in the United 
States (Honeywell Inc., 1998).  On average one 8oz (236 mL) container of aqueous 
benzalkonium chloride costs about $24.19 (Westbury Pharmacy, 2002).  With all the 
beneficial applications that Zephiran provides it would indicate that benzalkonium 
chloride is a very cost effective chemical in treating skin disorders, oral infections, and 
chemical burns.  Using iced benzalkonium chloride has some very beneficial advantages.   
It reduces local pain and slowing the rate of tissue destruction.  In addition Zephiran 
slows down the penetration of the fluoride ion into the skin tissues and blood stream from 
dermal exposure to hydrofluoric acid.  Unfortunately there has been evidence indicating 
even low concentrations of Zephiran can cause severe allergic reactions in humans (The 
American Academy of Optometry, 2002).  
It is hard to associate a cost to pain.  The process used for treating hydrofluoric 
acid burns is a painful process, despite the method of treatment.  It is known that 
prolonged immersion in iced benzalkonium chloride has lead to frost bite and cold 
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discomfort due to the chilling of benzalkonium chloride prior to treatment.  It should be 
noted that Zephiran should not be used on the faces, ears, eyes, or other areas that 
contain sensitive tissues due to its irritating nature.  Another negative cost associated with 
using Zephiran is the amount that is needed during in the treatment process (Honeywell 
Inc., 1998).  No data or information could be found on the total amount used during any 
treatment method process.  It should be noted that two studies (Dunn et al., 1992 & 
Bracken et al., 1985) indicated that the iced Zephiran soaked bandages were changed 
every two to four minute.   This would indicate that excessive amounts could be needed 
when treating larger burns. 
Calcium gluconate gel is a water-soluble lubricant that is mainly used for treating 
hydrofluoric burns.  This treatment is convenient to carry and can be used to initially treat 
small burns and can relieve dermal pain.  Calcium gluconate is useful for treating 
hydrofluoric acid burns on the face, ears, mouth, and eyes, because it is not an irritating 
agent (Honeywell Inc., 1998).  Some of the general benefits with using calcium gluconate 
are identified.  They are: 
• How easy it can be used 
• Can be self administered if needed 
• Can be applied immediately to a burn from hydrofluoric acid  
• It is painless when applied to the burned area 
• Calcium gluconate produces no risk of increasing mussel tension 
or tissue stress 
• The methods of administering include topical, opthalmical, and 
injection able 
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• It reduces the possibility of acquiring hypocalcemia 
• No specialized equipment is needed 
Another major cost benefit associated with calcium gluconate is the mixing your own 
solution.  Almost every local pharmacy can make up calcium gluconate solution without 
a doctors prescription, and is considerably cheaper than purchasing the treatment (Segal, 
1997).   
 The cost of calcium gluconate varies from supplier to supplier as seen in figure 9: 
Figure 9 – Cost Comparison of Calcium Gluconate Suppliers 
Suppliers 
Name 
Container 
Amount 
Cost for 
Container
Shelf 
Life Storage References  
Life Safety 
Associates 25 grams $31.95 2 year Refrigeration 
Life Safety 
Associates, 2002 
Attard's 
Minerals 60 grams $40.00 2 year
Room 
Temperature 
Attard's Minerals, 
2002 
Pharmascie
nce Inc. 25 grams $27.55 N/A N/A 
ORS Emergency 
Response, 2001 
Cameron 
Medical 25 grams $32.82 N/A N/A 
ORS Emergency 
Response, 2001 
 
The average cost of a 25-gram tube of calcium gluconate is $27.25 this does not take into 
consideration shipping and handling costs.  There are some different of options, as it 
relates to the storage of calcium gluconate.  Some producers state that room temperature 
is sufficient and other manufactures stress that calcium gluconate must be stored in a 
refrigerated unit (Life Safety Associates, 2002 & Attard's Minerals, 2002). 
A cost comparison should not just analyze how much a treatment or medicine 
costs.  The analysis should consider availability, side effects, and other pertinent 
information that may be important.  The cost difference between calcium gluconate and 
Zephiran®, is extremely large.  Zephiran® costs on average $4.84 per 25 grams 
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(Westbury Pharmacy, 2002) and calcium gluconate costs about $27.25 per 25 grams (Life 
Safety Associates, 2002 & Attard's Minerals, 2002 & ORS Emergency Response, 2001). 
It should be noted that calcium gluconate could be made by the local pharmacy for a 
lower cost.  Besides feasibility, treatment effectiveness and attainability are two very 
important consideration factors.  One negative aspect in using Zephiran® is it cannot be 
applied to the face, ears or other sensitive tissues.  Calcium gluconate can be applied to 
the face, ears and other sensitive tissues without the occurrence of any negative effects.  
Another benefit is that calcium gluconate can be stored at room temperature and 
transported without any special considerations.  Zephiran® must be kept in a frozen or 
refrigerated storage compartment because of the treatment method.  After identifying all 
the cost comparison factors between Zephiran® and calcium gluconate, it can be stated 
that calcium gluconate may cost more but its benefits do pay for themselves (Honeywell 
Inc., 1998).  One benefit is that calcium gluconate can be stored at room temperature 
another benefit is that calcium gluconate can be made at the local pharmacy, which 
reduces the cost significantly.  The treatment that is most effective and beneficial in 
treating hydrofluoric acid burns should be used despite the cost of the medicine or 
treatment methodologies.   
Summary 
Hydrofluoric acid is a very unique and complex chemical that needs to be used 
with extreme caution.  Overexposure to hydrofluoric acid can lead to serious injury and 
even death.  There are many ways that an overexposure to this chemical can happen.  The 
need for proper training, as well as other protective measures is essential in preventing 
injuries and illnesses from exposure to hydrofluoric acid. 
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Knowing what method of treatment to use for an exposure to hydrofluoric acid 
may mean the difference between life and death.  Studies performed by Bracken et al. 
(1985) and Dunn et al. (1992) indicated that calcium gluconate was by far was the most 
effective treatment for long-term dermal exposure to hydrofluoric acid.  In addition, 
Dunn et al. (1992) indicated that Zephiran® was the most effective treatment for short-
term dermal exposure to hydrofluoric acid.  Since Bracken et al. (1985) did not take into 
consideration the skin differences between rats and humans, the Bracken et al. (1985) 
study may not truly indicate the best dermal treatment for humans who are exposed to 
hydrofluoric acid.  When considering the available research based information, 
Zephiran® appeared to be the best method for short-term dermal exposure to 
hydrofluoric acid and calcium gluconate showed evidence as being the most effective 
treatment for long-term dermal exposure.  When applied to the operational aspect of an 
organization that utilizes hydrofluoric acid in its processes, this finding would not only 
determine the different forms of dermal treatment to be stocked, but also influence the 
training that associated employees would receive. 
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CHAPTER 3 
Methodology 
Introduction 
 The goal of this study was to evaluate Zephiran® and calcium gluconate in the 
treatment process for dermal exposure to hydrofluoric acid.  The purpose of this chapter 
was to identify how the researcher accomplished this activity.  The main objective of this 
study was to conduct an evaluation of policies that relate to treatment methodologies for 
dermal exposure to hydrofluoric acid.  More specifically, to determine whether 
Zephiran® or calcium gluconate was most desired by industry and universities today in 
treating dermal-based exposures to hydrofluoric acid.  The researcher used the following 
methodology to complete this study. 
Method of Study 
The researcher preformed a literature review on the toxicological effects of 
hydrofluoric acid.  This information was used to understand how the human body reacts 
when exposed to hydrofluoric acid.  The researcher examined the physical implications 
associated with dermal-based exposure to hydrofluoric acid through a literature review.  
This information was used to obtain an understanding of how the human body reacts 
when exposed to hydrofluoric acid.  Next the researcher analyzed topical-based treatment 
methodologies for dermal hydrofluoric acid exposure.  The researcher used Zephiran 
and calcium gluconate as the two topical-based treatments. Zephiran and calcium 
gluconate were used in this study because they have been used in previous studies.  
Through a literature review, the researcher determined the cost comparison between 
Zephiran and calcium gluconate.  This allowed users of Zephiran or calcium 
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gluconate to acquire a better understanding of costs associated with using one treatment 
over the other.  The last goal was to determine which topical based treatment, Zephiran 
or calcium gluconate was most desired by industry and universities today in treating 
dermal-based exposures to hydrofluoric acid.     
To accomplish this the researcher identified companies and universities that use 
hydrofluoric acid in their manufacturing process and laboratory studies.  The researcher 
obtained policies and procedures from ten companies and ten universities.  The policies 
and procedures were obtained through the Internet.  The Internet was used because it was 
the most easiest duplicated for locating treatment policies and procedures.  Next the 
researcher analyzed each set of policies and procedures to determine what treatment 
methodologies were most preferred for treating exposure to hydrofluoric acid.   
During the analysis process, three items were identified to determine which 
treatment methods were most preferred by companies and universities.  The first criteria 
identified the length of time that the exposed area should be rinsed with water.  This 
information was important because in most cases people exposed to hydrofluoric acid 
delay topical treatment by rinsing under a safety shower for to long.  The second criteria 
was to determine if the policies or procedures discussed removing all contaminated 
clothing immediately after being exposed to hydrofluoric acid.  This helps clarity if the 
companies and/or universities understand the importance of removing clothing once it 
has been contaminated.  This question was important because the clothing acts as a 
barrier between the hydrofluoric acid and the skin.  The third and final criteria identified 
whether Zephiran® or calcium gluconate was the preferred method of treatment.  The 
policies and procedures indicated whether to use Zephiran® or calcium gluconate in 
treatment method.  The data and information that was collected in the literature review 
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was compared to the information gathered from these policies.  The results and data 
collected from the answered criteria are detailed in the next chapter. 
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CHAPTER 4 
Results of Study 
Introduction & Discussion 
 The purpose of this chapter was to report the results of study.  
Toxicological effects and physical implications associated with dermal-based exposure to 
hydrofluoric acid were investigated.  Topical-based treatment methodologies for dermal 
hydrofluoric acid exposure as it relates to the use of Zephiran verses calcium gluconate 
was identified.  In addition, results from a cost comparison between Zephiran and 
calcium gluconate in the treatment of dermal exposure to hydrofluoric acid was 
delineated in this chapter.  Information on which topical based treatment (Zephiran or 
calcium gluconate) is most desired by industry and universities today in treating dermal-
based exposures to hydrofluoric acid is delineated in this chapter as well.  This was 
accomplished by identifying companies and universities that used hydrofluoric acid in 
their manufacturing process and laboratory studies.  Once identified the criteria from 
each treatment policy was noted and organized per company and university.  
Using the methodology that was delineated in Chapter 3, an assessment of 
treatment policies was conducted.  
 Goal #1 
Identify the toxicity and physical properties of hydrofluoric acid. 
• Hydrofluoric acid can also be referred to as anhydrous hydrogen fluoride, aqueous 
hydrogen fluoride or HF-A (National Institute for Occupational Safety and 
Health, 2000).    
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• Hydrofluoric acid is an extremely toxic and corrosive substance that can exit 
either as a gas, liquid, or solid form (National Safety Council, 1988). 
• Hydrofluoric acid will deteriorate materials such as concrete, glass, natural 
rubber, and metal alloys that contain silica (EPA Chemical Profile 1987).   
• Hydrofluoric acid is a corrosive substance that exits either as a gas, liquid, or solid 
that causes visible destruction or permanent changes in human skin tissue at the 
site of contact (National Safety Council, 1988). 
• From an acute exposure standpoint, it is estimated that exposure to air 
concentrations ranging from of 50 to 250 ppm of hydrofluoric acid for five 
minutes can be lethal (Hathaway, Proctor, Hughes, & Fischman, 1991). 
• A dermal overexposure to hydrofluoric acid can result in the formation of deep 
ulcers that are slow to heal.   
• In some cases these burns can be life threatening, specialized first aid and medical 
treatment is required for any exposure to hydrofluoric acid (Honeywell Inc., 
1998). 
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• Some unique properties of hydrofluoric acid are shown in Figure 10 
Figure 10 – Proprieties of Hydrofluoric Acid 
Boiling Point: 67 °F 19.44 °C 292.4 K 527 R 
Flammability:  Nonflammable Gas Lower Explosive Limit: N/A 
Vapor Pressure:  783 mmHg Upper Explosive Limit: N/A 
Incompatibilities: Corrosive to metals. Will attack glass and concrete. 
Target Organs: Eyes, skin, respiratory system, bones 
Symptoms: Irritation eyes, skin, nose, throat; pulmonary edema; eye, skin burns; bone changes 
Exposure Routes: Inhalation, skin absorption (liquid), ingestion (solution), skin and/or eye contact 
Physical 
Description: 
Colorless gas or fuming liquid (below 67°F) with a strong, irritating 
odor.  
 
Goal #2 
Examine the physical implications associated with dermal-based exposure to hydrofluoric 
acid. 
• Hydrofluoric acid reacts with the body in two ways: (Bracken, Cuppage, 
McLaury, Kirmin, & Klaassen, 1985) 
o First, dehydration induced coagulative necrosis occurs immediately upon 
dermal contact.  
o The second injury occurs when hydrofluoric acid penetrates tissues and 
starts to bind with calcium and magnesium, causing internal organ failure.  
Goals #3 
Determine topical-based treatment methodologies for dermal hydrofluoric acid exposure 
as it relates to the use of Zephiran verses calcium gluconate. 
• Dunn et al. (1992) stated that Zephiran® was the most effective treatment for 
short-term exposure to hydrofluoric acid.  
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• Dunn et al. (1992) concluded that Zephiran® was not as effective for long-term 
exposure.   
• Bracken et al. (1985) concluded that calcium gluconate is the most effective for 
treating skin that had been exposed to hydrofluoric acid.   
• Bracken et al. (1985) also indicated that Zephiran® is not an effective treatment 
for dermal exposure to hydrofluoric acid. 
• The results obtained from the Bracken et al. (1985) and Dunn et al. (1992) studies 
suggested that calcium gluconate was overall the most effective treatment in 
decreasing and delaying hydrofluoric acid burns. 
Goal #4 
Determining the cost comparison between Zephiran and calcium gluconate in the 
treatment of dermal exposure to hydrofluoric acid. 
• Figure 11 identifies a cost comparison between Zephiran® and calcium gluconate. 
Figure 11 - Cost Comparison Model Between Zephiran® & Calcium gluconate 
Treatments Cost per 25 Grams Storage Side Effects 
Zephiran® $4.84 Must Be Refrigerated Can Not Use On Sensitive Tissue/Known Allergen 
Calcium 
gluconate $27.25 
Room Temperature is 
Adequate 
Can Be Used On Sensitive 
Tissue/Not An Allergen 
 
Goal #5 
Determine which topical based treatment, Zephiran or calcium gluconate, is most 
desired by industry and universities today in treating dermal-based exposures to 
hydrofluoric acid.   
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• The following tables summarize the information that was collected from company 
and university treatment policies for exposure to hydrofluoric acid.  This 
information will be delineated and tabulated on the following pages: 
Figure 12 - Washing Times for Universities 
Source of Polices: Policies Rinsing Time Description: References: 
Boston Wash area for at least 5 minutes University of Boston, 2002 
California-Berkeley Wash area for 5 minutes University of California-Berkeley, 1997 
California-Davis Wash area for 5 minutes University of California-Davis, 2000 
California-Los Angels Wash area for 15 minutes University of California-Los Angels, 1997 
Delaware State Wash area for at least 1 minute University of Delaware, 2002 
Louisiana State Wash area for a minimum of 15 to 20 minutes 
University of Louisiana State, 
2001 
Northwestern Wash area for a maximum of 5 minutes University of Northwestern, 2001 
South Carolina State Wash area for a minimum of 5 minutes 
University of South Carolina, 
2000 
Washington State Wash area for a maximum of 5 minutes University of Washington, 2000 
Western Australia Wash area for a minimum of 10 minutes 
University of Western Australia, 
1999 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 - Clothing Statement in University Policies 
Source of Polices: Remove clothing was stated in policy: References: 
Boston Not Mentioned in Policy University of Boston, 2002 
California-Berkeley Yes, Stated in Policy University of California-Berkeley, 1997 
California-Davis Yes, Stated in Policy University of California-Davis, 2000 
California-Los Angels Yes, Stated in Policy University of California-Los Angels, 1997 
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Delaware State Yes, Stated in Policy University of Delaware, 2002 
Louisiana State Yes, Stated in Policy University of Louisiana State, 2001 
South Carolina State Yes, Stated in Policy University of South Carolina, 2000 
Northwestern Yes, Stated in Policy University of Northwestern, 2001 
Washington State Yes, Stated in Policy University of Washington, 2000 
Western Australia Yes, Stated in Policy University of Western Australia, 1999 
 
 
 
Figure 14 - Treatment Methods Stated in University Policies 
Treatment Method 
Source of Polices: 
% Concentration Suggested Treatment 
References: 
Boston 0.13 % & 2.5 % Zephiran® & Calcium gluconate University of Boston, 2002 
California-Berkeley N/A Calcium gluconate University of California-Berkeley, 1997 
California-Davis 2.5 % Calcium gluconate University of California-Davis, 2000 
California-Los Angels N/A Calcium gluconate University of California-Los Angels, 1997 
Delaware State 2.5 % Calcium gluconate University of Delaware, 2002 
Louisiana State 0.13 % Zephiran® University of Louisiana State, 2001 
Northwestern N/A Calcium gluconate University of Northwestern, 2001 
South Carolina State N/A Calcium gluconate University of South Carolina, 2000 
Washington State N/A Calcium gluconate University of Washington, 2000 
Western Australia N/A Calcium gluconate University of Western Australia, 1999 
 
 
 
Figure 15 - Washing Times for Companies 
Source of Polices: Policies Rinsing Time Description: References: 
AGA Gas, 
Incorporated No time specified AGA Gas, Incorporated, 2000 
Air Products Wash area for at least 5 minutes Air Products, 1999 
DuPont Wash area for 5 minutes DuPont, 2001 
EM Industries 
Incorporated Wash area for at least 15 minutes EM Industries Incorporated, 2001 
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Honeywell Inc.  Wash area for a minimum of 5 minutes Honeywell Inc., 2002 
Kendon Chemical & 
MNFG Corporation Wash area for at least 20 minutes 
Kendon Chemical & MNFG 
Corporation, 2000 
Mallinckrodt Baker, 
Inc.  Wash area for a minimum of 15 minutes Mallinckrodt Baker, Inc., 2001 
Omega Chemistries, 
Incorporated Wash area for a minimum of 5 minutes 
Omega Chemistries, 
Incorporated, 1999 
Regions Hospital 
Emergency Medical 
Services 
Wash area for 5 minutes Regions Hospital Emergency Medical Services, 2000 
WorkCover 
Corporation No time specified WorkCover Corporation, 2002 
 
 
 
Figure 16 -Clothing Statement in Company Policies 
Source of Polices: Remove clothing was stated in policy: References: 
AGA Gas, 
Incorporated Yes, Stated in Policy AGA Gas, Incorporated, 2000 
Air Products Yes, Stated in Policy Air Products, 1999 
DuPont Yes, Stated in Policy DuPont, 2001 
EM Industries 
Incorporated Yes, Stated in Policy EM Industries Incorporated, 2001 
Honeywell Inc.  Yes, Stated in Policy Honeywell Inc., 2002 
Kendon Chemical & 
MNFG Corporation Yes, Stated in Policy 
Kendon Chemical & MNFG 
Corporation, 2000 
Mallinckrodt Baker, 
Inc.  Yes, Stated in Policy Mallinckrodt Baker, Inc., 2001 
Omega Chemistries, 
Incorporated Yes, Stated in Policy 
Omega Chemistries, Incorporated, 
1999 
Regions Hospital 
Emergency Medical 
Services 
Yes, Stated in Policy Regions Hospital Emergency Medical Services, 2000 
WorkCover 
Corporation Yes, Stated in Policy WorkCover Corporation, 2002 
Figure 17 - Treatment Methods Stated in Company Policies 
Treatment Method 
Source of Polices: 
% Concentration Suggested Treatment 
References: 
AGA Gas, 
Incorporated N/A Calcium gluconate 
AGA Gas, Incorporated, 
2000 
Air Products 0.13 %& 2.5 % Zephiran® & Calcium gluconate Air Products, 1999 
DuPont 2.5 % Calcium gluconate DuPont, 2001 
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EM Industries 
Incorporated N/A 
Zephiran® & Calcium 
gluconate 
EM Industries 
Incorporated, 2001 
Honeywell Inc.  0.13 %& 2.5 % Zephiran® & Calcium gluconate Honeywell Inc., 2002 
Kendon Chemical 
& MNFG 
Corporation 
2.5 % Calcium gluconate Kendon Chemical & MNFG Corporation, 2000 
Mallinckrodt 
Baker, Inc.  0.13 %& 2.5 % 
Zephiran® & Calcium 
gluconate 
Mallinckrodt Baker, Inc., 
2001 
Omega 
Chemistries, 
Incorporated 
0.13 %& 2.5 % Zephiran® & Calcium gluconate 
Omega Chemistries, 
Incorporated, 1999 
Regions Hospital 
Emergency 
Medical Services 
Iced & N/A Zephiran® & Calcium gluconate 
Regions Hospital 
Emergency Medical 
Services, 2000 
WorkCover 
Corporation N/A Calcium gluconate 
WorkCover Corporation, 
2002 
 
Discussion 
 Collecting all the data from the different treatment policies indicated that calcium 
gluconate is the most noted treatment for dermal exposure to hydrofluoric acid.  It can 
also be stated that calcium gluconate is most cost effective than Zephiran® because it can 
be made cheaper by a farm iciest.  Calcium gluconate is more cost effective because of its 
shelf life and storage conditions are longer and less stringent than Zephiran®.   
In analyzing the rinsing time periods, the periods had a range between 1 minute 
and 20 minutes.  This range of time conflicts with the issue on how long treatment should 
be applies.  The longer treatment methods are delayed the more time is given for 
hydrofluoric acid to cause dermal destruction.  A large majority of the treatment policies 
indicated that clothing contaminated with hydrofluoric acid should be removed 
immediately.  All treatment policies were identified and studied to determine which 
topical` based treatment, Zephiran or calcium gluconate is most desired by industry and 
universities today in treating dermal-based exposures to hydrofluoric acid.  Out of the 20 
samples taken 95% stated that calcium gluconate may be used fro treating dermal 
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exposure to hydrofluoric acid.  Calcium gluconate by far was the more desired treatment 
method than Zephiran® as it relates to treating dermal exposure to hydrofluoric acid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5 
Conclusion & Recommandations 
Introduction 
 The purpose of this study was to compare the use of calcium gluconate 
and Zephiran for the treatment of dermal based hydrofluoric acid exposure.  In order to 
accomplish this, pertinent literature was reviewed in addition to analyzing policies and 
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procedures for treating dermal exposure to hydrofluoric acid.  Discussion, conclusions 
and recommendations are delineated in this chapter. 
Discussion 
 In order for the reader to follow the researcher thought pattern the previous 
chapters are summarized.  To summarize this study a restatement of the problem, 
methods used, and major findings are provided. 
Restatement of the Problem 
The purpose of this study was to compare two treatment methodologies that were 
used for treating dermal exposure to hydrofluoric acid.  Calcium gluconate and 
Zephiran were the two treatments used for comparison.  In order to accomplish this a 
review of pertinent literature was conducted.  An analysis of policies and procedures for 
treating dermal exposure to hydrofluoric acid was conducted.  The policies and 
procedures were obtained from a number of different universities and industries that use 
hydrofluoric acid in their experiments and manufacturing processes.  
Methods and Procedures 
 The study investigated the toxicological effects and physical implications that 
were associated with dermal exposure to hydrofluoric acid.  This was conducted by 
reviewing pertinent literature in addition to analyzing topical-based treatment 
methodologies for dermal exposure to hydrofluoric acid.  Zephiran and calcium 
gluconate were the two treatment methodologies studied.  A cost comparison between 
Zephiran and calcium gluconate was preformed.  The cost of Zephiran and calcium 
gluconate was determined by identifying suppliers of the two treatments.  The last 
objective was to determine which topical based treatment, Zephiran or calcium 
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gluconate, was most desired in universities and industry today.  This was conducted by 
identifying which universities and business used hydrofluoric acid in their production and 
experimental processes.  Finally, the policies and procedures were obtained for analysis.  
All the policies and procedures were acquired from Internet sites. 
Major Findings 
 In regards to the toxicological effects and physical implications associated with 
exposure to hydrofluoric acid, it can be stated that hydrofluoric acid is very toxic to 
humans (EPA Chemical Profile, 1987).  This is important to know because it identifies 
that hydrofluoric acid is dangerous and should be handled with care.  By knowing the 
dangers of hydrofluoric acid management can properly set up engineering and 
administrative controls for hydrofluoric acid.  From the analysis of Zephiran verses 
calcium gluconate in the treatment of dermal exposure to hydrofluoric acid, calcium 
gluconate was more effective than Zephiran (Dunn et al., 1992).  This is important to 
know because the most effective hydrofluoric acid dermal burn treatment needs to be 
used.  When determining which treatment is more cost effective benefits like storage, 
easy of application, and transportation issues need to be taken into consideration.  Thus 
calcium gluconate may have a larger direct cost than Zephiran, but benefits such as 
storage, easy application, and ease of transportation make calcium gluconate more cost 
effective than Zephiran.  In determining which topical based treatment, Zephiran or 
calcium gluconate, is most desired in industry and university settings an analysis of 
pertinent policies and procedures was conducted.  The results of the analysis indicated 
that 80% of universities suggested calcium gluconate for the treatment.  Ten out of ten 
industries indicated calcium gluconate for the treatment of dermal exposure to 
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hydrofluoric acid.  Out of the ten industry policies analyzed 60% indicated that 
Zephiran could be used for treating dermal exposure to hydrofluoric exposure if 
calcium gluconate is not available for treatment. 
Conclusion 
In conclusion, this study compared the use of calcium gluconate and Zephiran 
for the treatment of dermal based hydrofluoric acid exposure.  Throughout this study 
pertinent literature was reviewed in addition to analyzing policies and procedures for 
treating dermal exposure to hydrofluoric acid.  The researcher identified the toxicological 
effects and physical implications associated with dermal-based exposure to hydrofluoric 
acid.  Information ascertained form pertinent literature indicated that hydrofluoric acid is 
an extremely toxic and corrosive substance that can exit either as a gas, liquid, or solid 
form (National Safety Council, 1988).  The researcher can conclude that hydrofluoric 
acid should be handled with extreme causation. 
The information delineated in the studies (Bracken et al., 1985 & Dunn et al., 
1992) showed that calcium gluconate is a better treatment than Zephiran when treating 
skin that has been exposed to hydrofluoric acid.  Topical-based treatment methodologies 
for dermal hydrofluoric acid exposures were analyzed.  For this analysis it can be 
concluded that calcium gluconate may be more effective than Zephiran in treating 
dermal exposures to hydrofluoric acid.  A cost comparison between the two treatments 
indicated that calcium gluconate is a more cost effective than Zephiran.  Thus, it can be 
concluded that calcium gluconate may be less expensive than Zephiran® depending upon 
were the treatment is purchased.  A random sampling method was used in determining 
which topical based treatment was most desired by industry and universities today.  
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Calcium gluconate was identified as the main treatment that industries and universities 
use for treating exposure to hydrofluoric acid.  From the random sample taken 95% of the 
samples suggested calcium gluconate for the treatment of exposure to hydrofluoric acid.  
From this information it can be concluded that calcium gluconate maybe used more than 
Zephiran® for the treatment of dermal exposure to hydrofluoric acid.   
In summary, a review of pertinent literature it can be stated that calcium gluconate 
may be more effective at treating dermal burns that occur from exposure to hydrofluoric 
acid. Based on the previous stated information it can be conclude that calcium gluconate 
is more cost effective than Zephiran.  Calcium gluconate is more effective in treating 
dermal exposure to hydrofluoric acid than Zephiran.  From previously stated data it can 
be stated that universities and industries use calcium gluconate more than Zephiran 
when treating dermal exposure to hydrofluoric acid.   
Recommendations Related to this Study 
The researcher recommends that proper emergency policies need to be in place 
prior to using hydrofluoric acid in any amount.  Hydrofluoric acid has been identified as a 
corrosive substance, thus personal protective equipment must be worn when handling 
hydrofluoric acid.  Emergency eyewash and safety showers should be located in area 
where hydrofluoric acid is used.  Gloves, goggles, face shield, chemical resistant apron, 
and rubber boots should be worn when handling hydrofluoric acid.   
After reviewing pertinent literature on treatment methodologies for dermal 
exposure to hydrofluoric acid and reviewing policies and procedures from companies that 
use hydrofluoric acid the researcher can state that calcium gluconate should be used over 
Zephiran® for treating dermal exposure to hydrofluoric acid.  The researcher 
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recommends that either calcium gluconate or Zephiran® should be available for 
treatment depending on the policies or procedures of the facility.  The researcher notes 
that engineering controls should be used whenever possible, personal protective 
equipment and administrative controls should be the last option.   
Recommendations for Future Research 
It is recommended that further research should be done on finding a better 
methods for treating dermal exposure to hydrofluoric acid.  Future dermal-based research 
studies should use pig models for subjects because of the similarity between pig and 
human skin.   
 Future research should be performed using current treatment methods for dermal 
exposure to hydrofluoric acid and should expand on using more than one treatment 
methodology.  The research should also include the use of pig models and a number of 
different treatments that have not been mentioned in this study, such and calcium acetate 
or Hexafluorine.  Future researches should consider a wide spectrum of exposure periods 
and treatment methodologies prior to making any recommendations in the treating of 
dermal exposure to hydrofluoric acid. 
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